KLSMC Stem Cells Profile

KLSMC Stem Cells Sdn. Bhd., a subsidiary of Kuala Lumpur Sports Medicine Centre, was established in 2005 specifically to spearhead the research on stem cells regenerative therapy in the musculoskeletal system. Following internationally recognized medical research ethics and protocols, a series of studies were undertaken culminating in 2007 with the beginning of the human pilot study.

Several clinical studies led by Dr. Saw Khay Yong (consultant orthopaedic surgeon and CEO) revealed a breakthrough discovery: in injecting the patient’s own blood stem cells, coupled with surgical intervention and physiotherapy, it was possible for patients to regenerate hyaline cartilage.

In early 2010, a US patent (patent no: US 8,377,432 B2: Method and composition for neochondrogenesis) was filed for the stem cell technology and it was granted in 2013.

NICOLA’S AWARD 2008 for “Neochondrogenesis & Role of Stem Cells: An Experimental Study in Goat Model” at the 5th Meeting of the European Federation of National Associations of 2008 Orthopaedic Sports Traumatology (Antalya, Turkey; 26-30 December 2008).

BIOINNO AWARDS 2008 for medical research on “Articular Cartilage Regeneration with Stem Cells” at the BioMalaysia 2008 (Kuala Lumpur, Malaysia; 7-9 October 2008).

Latest News

Enterprise 50 is an annual award programme organised by the SME Corporation Malaysia (SME Corp.) and Deloitte Malaysia, with supporting sponsorship by RHB Bank Berhad and Telekom Malaysia Berhad (TM) to celebrate and highlight the achievements of enterprising small and medium companies that are well positioned for the future